lamivudine has been researched along with Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA | 1 |
Feingold, KR; Grunfeld, C; Khovidhunkit, W; Memon, RA; Mulligan, K; Pang, M; Schambelan, M; Shigenaga, JK | 1 |
2 other study(ies) available for lamivudine and Infections
Article | Year |
---|---|
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses | 2010 |
Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acquired Immunodeficiency Syndrome; Acute-Phase Proteins; Adult; Anti-HIV Agents; Cytokines; Female; HIV Infections; Humans; Infections; Lamivudine; Lipids; Lipoproteins; Male; Middle Aged; Phospholipases A; Protease Inhibitors | 1999 |